€10M
Horizon Europe — EU grant per project
Your DNADoesn't Change.Prescribing Should.
Clinical decision support powered by pharmacogenomics and AI
The solution
One Profile. A Lifetime of Smarter Prescribing.
Once a pharmacogenomic profile is generated, it can guide medication selection, dosing, and safety decisions whenever a relevant drug is prescribed.
- 01
Sequence Once
A one-time sample is sequenced to identify the clinically actionable genetic variants that influence drug response. No repeat testing — the same data supports prescribing decisions for years to come.
- 02
Interpret With Bioinformatics
An AI-assisted analysis layer processes the raw genomic data, flags clinically relevant variants, and structures them into standardized, prescribing-ready pharmacogenomic insights.
- 03
Generate a Pharmacogenomic Passport
The result is a lifelong profile that consolidates each patient's medication-relevant genetics into a single, portable record clinicians can reference at the point of care.
- 04
Integrate With Any Platform
Profiles surface across healthcare settings and systems — supporting consistent, evidence-based prescribing at both the individual and population level.
How could this look in practice?
Impact
The measurable impact of genetics-aware prescribing.
Why now
Limited Window
Europe is funding the build-out of sovereign health and biotech infrastructure across the current 2021–2027 cycle. The same money is available to every EU country — and whoever moves first sets the standard for the whole region. Lithuania has both the funding channels and the talent to do it first. The question isn't whether it gets built, but who and when.
Horizon Europe
EU funding matched to what we build
A matched EU Research & Innovation Action under Cluster 1 Health. Direct contribution covering 100% of eligible costs — and the call scope reads almost line-for-line like the GenoLink platform.
Full call details on the EU portal
€100K
Inovacijų agentūra — Lithuanian innovation funding
€300K
Eurostars 3 / Eureka — cross-border R&D
Our goals
Make genetics the backbone of every prescription — and grow from there into the medicine of the future.
We're building a system that uses genetic testing to help doctors make precise decisions — which drug, at what dose, and in what combination is safe for each patient. This reduces ineffective treatment, adverse reactions, and dosing errors — and, for the healthcare system, the cost of medications and the load on hospitals.
Stage 1 · Core2027–2028
AI recommendation platform
Analyzes the patient's genetic data and, at the moment of prescribing, helps the doctor choose the right drug and dose — and flags dangerous drug combinations.
Stage 22028–2029
In-house laboratory
A full cycle of genetic testing in Lithuania — from sample collection to interpretation and recommendations. Quality control at every step, fast turnaround, and sovereign data.
Stage 32029–2030
New fields and a scientific base
Building on a working system and accumulated data — expansion into new areas of medicine, new tests, and joint research with universities and clinics.
Why we do this
For patients
- Treatment matched to the individual genome
- The right drug and dose from the first prescription
- Fewer adverse reactions and ineffective treatments
For doctors
- A ready recommendation at the moment of prescribing
- No manual interpretation of genetics
- Lower risk, greater confidence in the decision
For the healthcare system
- Lower costs for complications and therapy selection
- Shorter hospital waiting times
- Citizens' data kept under control in Lithuania
Our team
Why us?
Young team combining expertise in Medicine, Biochemistry, and Bioinformatics, with hands-on experience in personalized medicine at AskBio and Bayer Pharmaceuticals. Our background ranges from VC-backed startups to leading teams and companies with multimillion-euro annual revenues. We believe the time for personalized healthcare is now, and with your support, we can make it more effective, efficient, and accessible for everyone.
Tomas Maksimovič
MSc Bioinformatics
Alan Rynkevič
Medical Student
Nikita Rancev
Serial entrepreneur
Precision Prescribing
Medication Safety
Pharmacogenomics
Personalised Medicine
Polypharmacy Intelligence
Clinical Decision Support
Population Health Analytics
Healthcare Efficiency
Treatment Optimization
Real-Time Alerts
PGx Interpretation
Outcome Analytics
Precision Prescribing
Medication Safety
Pharmacogenomics
Personalised Medicine
Polypharmacy Intelligence
Clinical Decision Support
Population Health Analytics
Healthcare Efficiency
Treatment Optimization
Real-Time Alerts
PGx Interpretation
Outcome Analytics
Precision Prescribing
Medication Safety
Pharmacogenomics
Personalised Medicine
Polypharmacy Intelligence
Clinical Decision Support
Population Health Analytics
Healthcare Efficiency
Treatment Optimization
Real-Time Alerts
PGx Interpretation
Outcome Analytics